Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

NF-kappaB activation stimulates transcription and replication of retrovirus XMRV in human B-lineage and prostate carcinoma cells.

Sakakibara S, Sakakibara K, Tosato G.

J Virol. 2011 Apr;85(7):3179-86. doi: 10.1128/JVI.02333-10. Epub 2011 Jan 26.

2.

Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.

Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M.

Nucleic Acids Res. 2008 Nov;36(20):6608-19. doi: 10.1093/nar/gkn666. Epub 2008 Oct 21.

3.
4.

LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.

Liu H, Zheng H, Duan Z, Hu D, Li M, Liu S, Li Z, Deng X, Wang Z, Tang M, Shi Y, Yi W, Cao Y.

Mol Cancer. 2009 Oct 27;8:92. doi: 10.1186/1476-4598-8-92.

5.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
6.
7.
8.

IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.

Song YJ, Jen KY, Soni V, Kieff E, Cahir-McFarland E.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2689-94. Epub 2006 Feb 13.

9.

Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus.

Kakoki K, Kamiyama H, Izumida M, Yashima Y, Hayashi H, Yamamoto N, Matsuyama T, Igawa T, Sakai H, Kubo Y.

Biochem Biophys Res Commun. 2014 Apr 25;447(1):216-22. doi: 10.1016/j.bbrc.2014.03.154. Epub 2014 Apr 8.

PMID:
24721431
10.

NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.

Chen CC, Liu HP, Chao M, Liang Y, Tsang NM, Huang HY, Wu CC, Chang YS.

Oncogene. 2014 Jul 10;33(28):3648-59. doi: 10.1038/onc.2013.345. Epub 2013 Aug 26.

PMID:
23975427
12.

Downregulation of APOBEC3G by xenotropic murine leukemia-virus related virus (XMRV) in prostate cancer cells.

Dey A, Mantri CK, Pandhare-Dash J, Liu B, Pratap S, Dash C.

Virol J. 2011 Dec 12;8:531. doi: 10.1186/1743-422X-8-531.

13.

Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.

Valentine R, Dawson CW, Hu C, Shah KM, Owen TJ, Date KL, Maia SP, Shao J, Arrand JR, Young LS, O'Neil JD.

Mol Cancer. 2010 Jan 5;9:1. doi: 10.1186/1476-4598-9-1.

14.

XMRV: usage of receptors and potential co-receptors.

Setty MK, Devadas K, Ragupathy V, Ravichandran V, Tang S, Wood O, Gaddam DS, Lee S, Hewlett IK.

Virol J. 2011 Sep 6;8:423. doi: 10.1186/1743-422X-8-423.

15.

Role of Ca2+/calmodulin-dependent kinase II-IRAK1 interaction in LMP1-induced NF-κB activation.

Kim JE, Kim SY, Lim SY, Kieff E, Song YJ.

Mol Cell Biol. 2014 Feb;34(3):325-34. doi: 10.1128/MCB.00912-13. Epub 2013 Nov 18.

16.

Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer.

Kim S, Kim N, Dong B, Boren D, Lee SA, Das Gupta J, Gaughan C, Klein EA, Lee C, Silverman RH, Chow SA.

J Virol. 2008 Oct;82(20):9964-77. doi: 10.1128/JVI.01299-08. Epub 2008 Aug 6.

17.

Utilization of replication-competent XMRV reporter-viruses reveals severe viral restriction in primary human cells.

Stürzel CM, Palesch D, Khalid M, Wissing S, Fischer N, Münch J.

PLoS One. 2013 Sep 13;8(9):e74427. doi: 10.1371/journal.pone.0074427. eCollection 2013.

18.
19.

Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.

Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry KA, Hu WS, Pathak VK.

J Virol. 2010 Jun;84(11):5719-29. doi: 10.1128/JVI.00134-10. Epub 2010 Mar 24.

20.

XMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model?

Stieler K, Schumacher U, Horst AK, Fischer N.

PLoS One. 2012;7(7):e42321. doi: 10.1371/journal.pone.0042321. Epub 2012 Jul 27.

Supplemental Content

Support Center